We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 1,371,413 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.45 | 0.55 | 0.50 | 0.50 | 0.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 543k | -609k | -0.0020 | -2.50 | 1.52M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:04:06 | O | 400,000 | 0.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 16/6/2025 | 07:00 | UK RNS | Physiomics PLC New Head of Biometrics and Two Contracts Awarded |
| 29/5/2025 | 07:00 | UK RNS | Physiomics PLC Physiomics Awarded Contract Extension |
| 09/5/2025 | 13:06 | ALNC |  Physiomics wins clinical development contract with new UK client |
| 09/5/2025 | 07:00 | UK RNS | Physiomics PLC Contract Award with New UK Client |
| 07/5/2025 | 16:45 | UK RNS | Physiomics PLC AIM Rule 17 and Schedule 2(g) Update |
| 17/4/2025 | 07:00 | UK RNS | Physiomics PLC Physiomics Awarded New Contract |
| 16/4/2025 | 07:00 | UK RNS | Physiomics PLC Publication of Peer Reviewed Article |
| 15/4/2025 | 18:23 | ALNC | Physiomics extends long-term collaboration with Numab via new contract |
| 15/4/2025 | 08:06 | ALNC | *Physiomics enters new contract with Numb Therapeutics, completion in next.. |
| 15/4/2025 | 07:00 | UK RNS | Physiomics PLC Contract Award |
Physiomics (PYC) Share Charts1 Year Physiomics Chart |
|
1 Month Physiomics Chart |
Intraday Physiomics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/6/2025 | 10:31 | Shares have the potential to multibag from 0.47p | 59 |
| 18/6/2025 | 22:26 | Physiomics - Cancer Treatment tech firm working with Merck + Oxford Uni | 11,831 |
| 22/1/2025 | 17:06 | Improving drug development | 1 |
| 17/6/2021 | 07:23 | PHYSIOMICS plc Virtual Tumor platform | 4,957 |
| 28/3/2021 | 22:05 | Physiomics PYC 2021 DISCUSSION (MODERATED) | 5 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:04:07 | 0.50 | 400,000 | 2,000.00 | O |
| 07:47:44 | 0.47 | 50,000 | 232.50 | O |
| 07:46:34 | 0.50 | 208,019 | 1,044.05 | O |
| 07:26:12 | 0.47 | 414,400 | 1,926.96 | O |
| 07:15:43 | 0.47 | 298,994 | 1,390.32 | O |
| Top Posts |
|---|
Posted at 20/6/2025 09:20 by Physiomics Daily Update Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 0.50p.Physiomics currently has 303,208,718 shares in issue. The market capitalisation of Physiomics is £1,516,044. Physiomics has a price to earnings ratio (PE ratio) of -2.50. This morning PYC shares opened at 0.50p |
Posted at 16/6/2025 22:49 by thiopia LOL what a pathetic person this is thinking an anonymous internet forum user can have any effect on a Company or share price... well certainly not affect a decent Company with decent Management poor snowflake must think his weak atrocious investment needs protectingRavenrussia 16 Jun '25 - 18:20 - 52 of 53 Meanwhile, I have forwarded Thiopias comments and comments about PYC and its directors to ADVFN and the legal team at Physiomics |
Posted at 16/6/2025 15:26 by z1co Zak Mir is bullish on the stockPhysiomics (PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announced the recruitment of Mr Jesse Thissen as Head of Biometrics, as well as the signing of the Company’s first ever two Biometrics contracts. The combined estimated value of both contracts is £111,000. Comment: Although the £111,000 number is not quite up to FTSE 100 level, the market cap of PYC is so small that it can and does very often make a difference to the share price. |
Posted at 07/6/2025 13:00 by z1co RaverussiaIndeed the company since 07th June 2024 has won 11 contracts worth in excess of £1,000,000 and with quite a few new customers. Share price very soon will begin to rerate substantially higher. |
Posted at 06/6/2025 09:30 by z1co thiopia , you're the biggest clown on this forum !The idiot was saying share price will hit 10p thiopia9 Jan '23 - 11:53 - 10502 of 11795 0 1 1 10p on today ? |
Posted at 05/6/2025 23:57 by z1co If you had any self respect you would not even post any more after getting yourself humiliated on this thread.thiopia the dirty little sewer rat was once ramping share price will hit 10p and now the low life scum bag is a full time deramper. You've been done so now you can foff. Hope that helps you |
Posted at 05/6/2025 18:32 by z1co Any decent news regarding PREDICT-ONC trial or DoseMe will send the share price up by 100% to 500%. |
Posted at 05/6/2025 15:53 by thiopia Be careful of fraudster pump and dumper Laura/RiddlerTroutisout1 Posted in: PYC Posts: 1,135 Price: 0.475 No Opinion RE: Is there Today 12:38 Looks like I am being targeted by Laura's Mob, the TR1 holder who completely misjudged the timing and spent 3 times as much as they could have done a month and a bit later. Can't tell the difference between posters either replying to me for someone else's post. It's simple, Laura spends too much time pumping this everywhere, every now and then that attracts a pump and dump, if you can see that and I did 6 months ago when Laura did that on the FAB board when they got their grant award. I came over here like Laura told everyone on the FAB board to do and immediately saw the set up here. Since then I have played the game but sold on a rise and bought back on the fall. Some of the posters here helped me to offload when they were buying at 1.1-1.2p levels and I thank you for that opportunity. You see PYC can be a very illiquid share sometimes and to get out you have to accept a lower price. So buy when it is low and sell when it spikes up and before they shut down the sell side. Yes there is a danger of news and the price continuing up but recent contract RNSs have seen the price fall, which shows there are a lot of 'hope' investors out there. So without a big piece of unexpected news the share price is likely to hover around here, we haven't seen enough time over 0.5p to see what the recent placees might do when faced with a profit, so comfortable with the way I am playing it and accruing profits on the way. Still hold just under 3m of these the last buy was the one Laura mentioned on 2nd June, the previous one was 965990 on 27th May and sold that one on 3rd June. I have no emotional attachment to PYC but it has given me a chance to make lots of profit as the game keeps getting played by Laura and gang. You either get ahead of the game or die by the sword. |
Posted at 04/6/2025 11:05 by z1co The share price is heading back towards 0.80p to 1p over the coming days. |
Posted at 29/5/2025 12:16 by bobdown2 I had these years ago. And its a shame that none of its progress is represented in the share price..it is one of aims illiquid shares where good news gives larger holders the ability to sell out. Normally fed up and at a loss.Today pyc had another validation of its product and revenue to add to other recent and longer term revenues. Its aim..progress us sold down. Loads have stopped investing on aim. And about 50% of posts should be filtered. Well done pyc. At some stage you will be rewarded. Even if its on aim |
Posted at 07/1/2025 22:47 by thiopia Comparing TCF and PYC for upside potentialTCF - Theracryf PYC - Physiomics TCF - share price 0.75p Mkt Cap £3m PYC - share price 0.75p Mkt Cap £1.5m Potential Catalysts ? PYC - consulting contracts ? software/IP development with partners such as DoseMeRX / Beyond Blood Diagnostics ? Government grants to run NHS trials ? TCF - has an existing $160m deal with Stalicla where a $0.5m milestone payment has been due/overdue for 12 months and another $5m milestone could be imminent for their Autism candidate. TCF claim to be in amicable discussions with Stalicla to resolve this issue. $0.5m would be very meaningful to a £3m company. $5m utterly transformational. 52 week high as of (Jan 2025) TCF - 1.85p PYC - 1.85p Charting w.r.t 50/200 day Moving Averages TCF is currently above the 50 and 200 day Moving Averages PYC is currently in between narrowing 50 and 200 Moving Averages |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
